{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T19:19:10Z","timestamp":1790191150934,"version":"4.1.0"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.neuropharm.2021.108449","type":"journal-article","created":{"date-parts":[[2021,1,12]],"date-time":"2021-01-12T22:57:16Z","timestamp":1610492236000},"page":"108449","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Effects of the NKCC1 inhibitors bumetanide, azosemide, and torasemide alone or in combination with phenobarbital on seizure threshold in epileptic and nonepileptic mice"],"prefix":"10.1016","volume":"185","author":[{"given":"Philip","family":"Hampel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerstin","family":"R\u00f6mermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f6rn","family":"Gailus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Johne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birthe","family":"Gericke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edith","family":"Kaczmarek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"L\u00f6scher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2021.108449_bib1","series-title":"Cell Physiology Sourcebook","first-page":"221","article-title":"Intracellular chloride regulation","author":"Alvarez-Leefmans","year":"2012"},{"key":"10.1016\/j.neuropharm.2021.108449_bib2","doi-asserted-by":"crossref","first-page":"107422","DOI":"10.1016\/j.pharmthera.2019.107422","article-title":"Impaired chloride homeostasis in epilepsy: molecular basis, impact on treatment, and current treatment approaches","volume":"205","author":"Auer","year":"2020","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2021.108449_bib3","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.expneurol.2011.12.014","article-title":"Inter-individual variation in the anticonvulsant effect of phenobarbital in the pilocarpine rat model of temporal lobe epilepsy","volume":"234","author":"Bankstahl","year":"2012","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2021.108449_bib4","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.eplepsyres.2013.09.014","article-title":"Pilocarpine-induced epilepsy in mice alters seizure thresholds and the efficacy of antiepileptic drugs in the 6-Hertz psychomotor seizure model","volume":"107","author":"Bankstahl","year":"2013","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.neuropharm.2021.108449_bib5","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0920-1211(01)00302-3","article-title":"Pharmacological characterization of the 6 Hz psychomotor seizure model of partial epilepsy","volume":"47","author":"Barton","year":"2001","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.neuropharm.2021.108449_bib6","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1177\/1073858412438697","article-title":"The GABA excitatory\/inhibitory shift in brain maturation and neurological disorders","volume":"18","author":"Ben Ari","year":"2012","journal-title":"Neuroscientist"},{"key":"10.1016\/j.neuropharm.2021.108449_bib7","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.tins.2017.07.001","article-title":"NKCC1 chloride importer antagonists attenuate many neurological and psychiatric disorders","volume":"40","author":"Ben Ari","year":"2017","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108449_bib8","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/nrd2997","article-title":"Key factors in the discovery and development of new antiepileptic drugs","volume":"9","author":"Bialer","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.neuropharm.2021.108449_bib9","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1111\/j.1528-1167.2008.01797.x","article-title":"Assessment of seizure susceptibility in pilocarpine epileptic and nonepileptic Wistar rats and of seizure reinduction with pentylenetetrazole and electroshock models","volume":"50","author":"Blanco","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2021.108449_bib10","doi-asserted-by":"crossref","first-page":"8602","DOI":"10.1523\/JNEUROSCI.0633-10.2010","article-title":"Disease-modifying effects of phenobarbital and the NKCC1 inhibitor bumetanide in the pilocarpine model of temporal lobe epilepsy","volume":"30","author":"Brandt","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108449_bib11","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.neuropharm.2018.09.025","article-title":"Bumepamine, a brain-permeant benzylamine derivative of bumetanide, does not inhibit NKCC1 but is more potent to enhance phenobarbital's anti-seizure efficacy","volume":"143","author":"Brandt","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2021.108449_bib12","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1016\/0024-3205(85)90573-9","article-title":"Variation in threshold and pattern of electroshock-induced seizures in rats depending on site of stimulation","volume":"37","author":"Browning","year":"1985","journal-title":"Life Sci."},{"key":"10.1016\/j.neuropharm.2021.108449_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/48a011e6-e4d0-4706-9a28-857eba8cfb31","article-title":"Bumetanide enhances phenobarbital efficacy in a rat model of hypoxic neonatal seizures","volume":"8","author":"Cleary","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.neuropharm.2021.108449_bib14","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/WCO.0b013e328337f451","article-title":"Mechanisms of cerebral edema in traumatic brain injury: therapeutic developments","volume":"23","author":"Donkin","year":"2010","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.neuropharm.2021.108449_bib15","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1111\/epi.13346","article-title":"The bumetanide prodrug BUM5, but not bumetanide, potentiates the antiseizure effect of phenobarbital in adult epileptic mice","volume":"57","author":"Erker","year":"2016","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2021.108449_bib16","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.eplepsyres.2006.01.005","article-title":"Antiepileptic effect of loop diuretics? Comment to \"Differential effects of cation-chloride co-transport-blocking diuretics in a rat hippocampal slice model of epilepsy\" by Margineanu, Klitgaard","volume":"69","author":"Frey","year":"2006","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.neuropharm.2021.108449_bib17","series-title":"Antiepileptic Drugs","first-page":"341","article-title":"Antiepileptic drug development program","author":"Gladding","year":"1985"},{"key":"10.1016\/j.neuropharm.2021.108449_bib18","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.tins.2017.03.006","article-title":"Chloride dysregulation, seizures, and cerebral edema: a relationship with therapeutic potential","volume":"40","author":"Glykys","year":"2017","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108449_bib19","first-page":"805","article-title":"Attenuation of azosemide's action in the loop of Henle of rat kidney by nonsteroidal anti-inflammatory drugs","volume":"41","author":"Greven","year":"1991","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.neuropharm.2021.108449_bib20","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.expneurol.2007.06.021","article-title":"Behavioral alterations in the pilocarpine model of temporal lobe epilepsy in mice","volume":"207","author":"Gr\u00f6ticke","year":"2007","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2021.108449_bib21","series-title":"The Search for Brain-Permeant NKCC1 Inhibitors for the Treatment of Seizures: Pharmacokinetic-Pharmacodynamic Modelling of NKCC1 Inhibition by Azosemide, Torasemide and Bumetanide in Mouse Brain","author":"Hampel","year":"2020"},{"key":"10.1016\/j.neuropharm.2021.108449_bib22","doi-asserted-by":"crossref","first-page":"9877","DOI":"10.1038\/s41598-018-27995-w","article-title":"Azosemide is more potent than bumetanide and various other loop diuretics to inhibit the sodium-potassium-chloride-cotransporter human variants hNKCC1A and hNKCC1B","volume":"8","author":"Hampel","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2021.108449_bib23","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/ana.1136","article-title":"Are certain diuretics also anticonvulsants?","volume":"50","author":"Hesdorffer","year":"2001","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2021.108449_bib24","series-title":"Vascularmechanisms in CNS Trauma, Springer Series in Translational Stroke Research, 5","first-page":"29","article-title":"Mechanisms of cerebral edema leading to early seizures after traumatic brain injury","author":"Iffland","year":"2020"},{"key":"10.1016\/j.neuropharm.2021.108449_bib25","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1111\/j.1471-4159.1993.tb13648.x","article-title":"Ionic composition of cisternal CSF in acute respiratory acidosis: lack of effect of large dose bumetanide","volume":"61","author":"Javaheri","year":"1993","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2021.108449_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3171\/FOC\/2008\/25\/9\/E22","article-title":"The bumetanide-sensitive Na-K-2Cl cotransporter NKCC1 as a potential target of a novel mechanism-based treatment strategy for neonatal seizures","volume":"25","author":"Kahle","year":"2008","journal-title":"Neurosurg. Focus"},{"key":"10.1016\/j.neuropharm.2021.108449_bib27","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1152\/physiol.00015.2009","article-title":"Molecular mechanisms of ischemic cerebral edema: role of electroneutral ion transport","volume":"24","author":"Kahle","year":"2009","journal-title":"Physiology"},{"key":"10.1016\/j.neuropharm.2021.108449_bib28","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/nrn3819","article-title":"Cation-chloride cotransporters in neuronal development, plasticity and disease","volume":"15","author":"Kaila","year":"2014","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108449_bib30","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1535-7597.2002.00013.x","article-title":"Diuretics as antiepileptic drugs","volume":"2","author":"Kanner","year":"2002","journal-title":"Epilepsy Current"},{"key":"10.1016\/j.neuropharm.2021.108449_bib31","doi-asserted-by":"crossref","first-page":"310","DOI":"10.3389\/fnins.2019.00310","article-title":"Off-Label use of bumetanide for brain disorders: an overview","volume":"13","author":"Kharod","year":"2019","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108449_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2307\/3570549","article-title":"Chemical protection against ionizing radiation. I. Sampling methods for screening compounds in radiation protection studies with mice","volume":"7","author":"Kimball","year":"1957","journal-title":"Radiat. Res."},{"key":"10.1016\/j.neuropharm.2021.108449_bib33","doi-asserted-by":"crossref","first-page":"4891","DOI":"10.1113\/jphysiol.2008.156281","article-title":"Epileptiform activities in slices of hippocampus from mice after intra-hippocampal injection of kainic acid","volume":"586","author":"Le Duigou","year":"2008","journal-title":"J. Physiol."},{"key":"10.1016\/j.neuropharm.2021.108449_bib34","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/(SICI)1099-081X(199707)18:5<371::AID-BDD40>3.0.CO;2-L","article-title":"Effect of phenobarbital, 3-methylcholanthrene, and chloramphenicol pretreatment on the pharmacokinetics and pharmacodynamics of azosemide in rats","volume":"18","author":"Lee","year":"1997","journal-title":"Biopharm Drug Dispos."},{"key":"10.1016\/j.neuropharm.2021.108449_bib35","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.brainres.2008.04.047","article-title":"Long-term expressional changes of Na+ -K+ -Cl- co-transporter 1 (NKCC1) and K+ -Cl- co-transporter 2 (KCC2) in CA1 region of hippocampus following lithium-pilocarpine induced status epilepticus (PISE)","volume":"1221","author":"Li","year":"2008","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2021.108449_bib36","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.jchromb.2011.02.018","article-title":"Sensitive isotope dilution liquid chromatography\/tandem mass spectrometry method for quantitative analysis of bumetanide in serum and brain tissue","volume":"879","author":"Li","year":"2011","journal-title":"J Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.neuropharm.2021.108449_bib37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0194552","article-title":"Clustering of spontaneous recurrent seizures separated by long seizure-free periods: an extended video-EEG monitoring study of a pilocarpine mouse model","volume":"13","author":"Lim","year":"2018","journal-title":"PloS One"},{"key":"10.1016\/j.neuropharm.2021.108449_bib38","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/pr.2012.7","article-title":"Bumetanide augments the neuroprotective efficacy of phenobarbital plus hypothermia in a neonatal hypoxia-ischemia model","volume":"71","author":"Liu","year":"2012","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.neuropharm.2021.108449_bib39","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0920-1211(88)90054-X","article-title":"Which animal models should be used in the search for new antiepileptic drugs? A proposal based on experimental and clinical considerations","volume":"2","author":"L\u00f6scher","year":"1988","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.neuropharm.2021.108449_bib40","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0920-1211(91)90075-Q","article-title":"The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. II. Maximal electroshock seizure models","volume":"8","author":"L\u00f6scher","year":"1991","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.neuropharm.2021.108449_bib41","first-page":"17","article-title":"Basic mechanisms of seizure propagation: targets for rational drug design and rational polypharmacy","volume":"11","author":"L\u00f6scher","year":"1996","journal-title":"Epilepsy Res. Suppl."},{"key":"10.1016\/j.neuropharm.2021.108449_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2009.03.025","article-title":"Preclinical assessment of proconvulsant drug activity and its relevance for predicting adverse events in humans","volume":"610","author":"L\u00f6scher","year":"2009","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2021.108449_bib43","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.seizure.2011.01.003","article-title":"Critical review of current animal models of seizures and epilepsy used in the discovery and development of new antiepileptic drugs","volume":"20","author":"L\u00f6scher","year":"2011","journal-title":"Seizure"},{"key":"10.1016\/j.neuropharm.2021.108449_bib44","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.neuropharm.2012.05.045","article-title":"Cation-chloride cotransporters NKCC1 and KCC2 as potential targets for novel antiepileptic and antiepileptogenic treatments","volume":"69","author":"L\u00f6scher","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2021.108449_bib45","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.eplepsyres.2016.05.016","article-title":"Fit for purpose application of currently existing animal models in the discovery of novel epilepsy therapies","volume":"126","author":"L\u00f6scher","year":"2016","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.neuropharm.2021.108449_bib46","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1007\/s11064-016-2025-7","article-title":"The search for new screening models of pharmacoresistant epilepsy: is induction of acute seizures in epileptic rodents a suitable Approach?","volume":"42","author":"L\u00f6scher","year":"2017","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neuropharm.2021.108449_bib47","doi-asserted-by":"crossref","first-page":"4469","DOI":"10.1111\/bph.13231","article-title":"Structure-activity relationships of bumetanide derivatives: correlation between diuretic activity in dogs and inhibition of human NKCC2 variant A","volume":"172","author":"Lykke","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2021.108449_bib48","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1111\/j.1528-1167.2011.03203.x","article-title":"Diuretics and epilepsy: will the past and present meet?","volume":"52","author":"Maa","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2021.108449_bib49","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1097\/WNR.0b013e328338ba18","article-title":"The pharmacokinetics of commonly used antiepileptic drugs in immature CD1 mice","volume":"21","author":"Markowitz","year":"2010","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuropharm.2021.108449_bib50","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/j.1528-1157.1997.tb01125.x","article-title":"Anticonvulsant activity of pyrid-3-yl-sulfonyl ureas and thioureas","volume":"38","author":"Masereel","year":"1997","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2021.108449_bib51","series-title":"JASPER'S BASIC MECHANISMS OF THE EPILEPSIES","first-page":"581","article-title":"Chloride homeostasis and GABA signaling in temporal lobe epilepsy","author":"Miles","year":"2012"},{"key":"10.1016\/j.neuropharm.2021.108449_bib52","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1007\/s00424-013-1342-9","article-title":"Ion transporters in brain endothelial cells that contribute to formation of brain interstitial fluid","volume":"466","author":"Mokgokong","year":"2014","journal-title":"Pfl\u00fcgers Archiv"},{"key":"10.1016\/j.neuropharm.2021.108449_bib53","first-page":"66","article-title":"Pharmacological properties of 3-n-butylamino-4-phenoxy-5-sulfamylbenzoic acid (Bumetanide), a new potent diuretic","volume":"22","author":"Ostergaard","year":"1972","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.neuropharm.2021.108449_bib54","doi-asserted-by":"crossref","first-page":"8465","DOI":"10.1073\/pnas.0602979103","article-title":"Anomalous levels of Cl- transporters in the hippocampal subiculum from temporal lobe epilepsy patients make GABA excitatory","volume":"103","author":"Palma","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.neuropharm.2021.108449_bib55","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.siny.2013.04.005","article-title":"Newly emerging therapies for neonatal seizures","volume":"18","author":"Pressler","year":"2013","journal-title":"Semin. Fetal Neonatal Med."},{"key":"10.1016\/j.neuropharm.2021.108449_bib56","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S1474-4422(14)70303-5","article-title":"Bumetanide for the treatment of seizures in newborn babies with hypoxic ischaemic encephalopathy (NEMO): an open-label, dose finding, and feasibility phase 1\/2 trial","volume":"14","author":"Pressler","year":"2015","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neuropharm.2021.108449_bib57","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1111\/epi.12620","article-title":"Pharmacotherapeutic targeting of cation-chloride cotransporters in neonatal seizures","volume":"55","author":"Puskarjov","year":"2014","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2021.108449_bib58","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.eplepsyres.2012.09.015","article-title":"The intrahippocampal kainate model of temporal lobe epilepsy revisited: epileptogenesis, behavioral and cognitive alterations, pharmacological response, and hippoccampal damage in epileptic rats","volume":"103","author":"Rattka","year":"2013","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.neuropharm.2021.108449_bib59","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1177\/1074248413497257","article-title":"Diuretics: a review and update","volume":"19","author":"Roush","year":"2014","journal-title":"J. Cardiovasc. Pharmacol. Therapeut."},{"key":"10.1016\/j.neuropharm.2021.108449_bib60","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.neuropharm.2017.02.006","article-title":"Multiple blood-brain barrier transport mechanisms limit bumetanide accumulation, and therapeutic potential, in the mammalian brain","volume":"117","author":"R\u00f6mermann","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2021.108449_bib61","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1152\/physrev.2000.80.1.211","article-title":"Sodium-potassium-chloride cotransport","volume":"80","author":"Russell","year":"2000","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.neuropharm.2021.108449_bib62","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/nprot.2008.73","article-title":"Analyzing real-time PCR data by the comparative C(T) method","volume":"3","author":"Schmittgen","year":"2008","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.neuropharm.2021.108449_bib63","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0920-1211(98)00058-8","article-title":"Osmolarity, ionic flux, and changes in brain excitability","volume":"32","author":"Schwartzkroin","year":"1998","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.neuropharm.2021.108449_bib64","doi-asserted-by":"crossref","first-page":"622","DOI":"10.3171\/2009.11.JNS081052","article-title":"Molecular mechanisms of microvascular failure in central nervous system injury-synergistic roles of NKCC1 and SUR1\/TRPM4","volume":"113","author":"Simard","year":"2010","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.neuropharm.2021.108449_bib65","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1535-7597.2002.00018.x","article-title":"Diuretics as antiepileptic drugs: should we go with the flow?","volume":"2","author":"Staley","year":"2002","journal-title":"Epilepsy Current"},{"key":"10.1016\/j.neuropharm.2021.108449_bib66","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.expneurol.2016.07.009","article-title":"Activation of GABA(A) receptors controls mesiotemporal lobe epilepsy despite changes in chloride transporters expression: in vivo and in silico approach","volume":"284","author":"Stamboulian-Platel","year":"2016","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2021.108449_bib67","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1111\/epi.16531","article-title":"Evaluation of subchronic administration of antiseizure drugs in spontaneously seizing rats","volume":"61","author":"Thomson","year":"2020","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2021.108449_bib68","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/ana.24124","article-title":"A novel prodrug-based strategy to increase effects of bumetanide in epilepsy","volume":"75","author":"T\u00f6llner","year":"2014","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2021.108449_bib69","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ejphar.2014.10.056","article-title":"Bumetanide is not capable of terminating status epilepticus but enhances phenobarbital efficacy in different rat models","volume":"746","author":"T\u00f6llner","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2021.108449_bib70","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/ejn.12424","article-title":"Consequences of inhibition of bumetanide metabolism in rodents on brain penetration and effects of bumetanide in chronic models of epilepsy","volume":"39","author":"T\u00f6pfer","year":"2014","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2021.108449_bib71","doi-asserted-by":"crossref","first-page":"C316","DOI":"10.1152\/ajpcell.00517.2010","article-title":"Ischemia-induced stimulation of Na-K-Cl cotransport in cerebral microvascular endothelial cells involves AMP kinase","volume":"301","author":"Wallace","year":"2011","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.neuropharm.2021.108449_bib72","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1111\/j.1528-1167.2008.01552.x","article-title":"The anticonvulsant profile of rufinamide (CGP 33101) in rodent seizure models","volume":"49","author":"White","year":"2008","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2021.108449_bib73","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/BF00582640","article-title":"Torasemide inhibits NaCl reabsorption in the thick ascending limb of the loop of Henle","volume":"407","author":"Wittner","year":"1986","journal-title":"Pfl\u00fcgers Archiv"},{"key":"10.1016\/j.neuropharm.2021.108449_bib74","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0920-1211(98)00008-4","article-title":"Frontal versus transcorneal stimulation to induce maximal electroshock seizures or kindling in mice and rats","volume":"30","author":"Wlaz","year":"1998","journal-title":"Epilepsy Res."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390821000034?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390821000034?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T07:08:09Z","timestamp":1758438489000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390821000034"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":73,"alternative-id":["S0028390821000034"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2021.108449","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of the NKCC1 inhibitors bumetanide, azosemide, and torasemide alone or in combination with phenobarbital on seizure threshold in epileptic and nonepileptic mice","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2021.108449","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108449"}}